Trial Outcomes & Findings for THA Kinematics and Sound for Subjects Implanted Using Various Surgical Approaches (NCT NCT01833481)

NCT ID: NCT01833481

Last Updated: 2019-10-10

Results Overview

Determine amount of in vivo swing phase hip separation present within implanted hip during weight-bearing level walking while under fluoroscopic surveillance.

Recruitment status

COMPLETED

Target enrollment

30 participants

Primary outcome timeframe

6 months post-operatively

Results posted on

2019-10-10

Participant Flow

Participant milestones

Participant milestones
Measure
THA Using Direct-anterior Surgical Approach
Patients will have undergone THA using a direct-anterior surgical approach and will undergo fluoroscopy surveillance while walking. Fluoroscopy surveillance of patients while walking: While each subject performs a gait activity (normal walking) under fluoroscopic surveillance on a level treadmill, a data acquisition (DAQ) system will be used to determine the vibrations/sounds occurring during walking.
THA Using Anterior-lateral Approach
Patients will have undergone THA using an anterior-lateral surgical approach and will undergo fluoroscopy surveillance while walking. Fluoroscopy surveillance of patients while walking: While each subject performs a gait activity (normal walking) under fluoroscopic surveillance on a level treadmill, a data acquisition (DAQ) system will be used to determine the vibrations/sounds occurring during walking.
THA Using Posterior-lateral Approach
Patients will have undergone THA using a posterior-lateral surgical approach and will undergo fluoroscopy surveillance while walking. Fluoroscopy surveillance of patients while walking: While each subject performs a gait activity (normal walking) under fluoroscopic surveillance on a level treadmill, a data acquisition (DAQ) system will be used to determine the vibrations/sounds occurring during walking.
Overall Study
STARTED
10
10
10
Overall Study
COMPLETED
10
10
10
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

THA Kinematics and Sound for Subjects Implanted Using Various Surgical Approaches

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
THA Using Direct-anterior Surgical Approach
n=10 Participants
Patients will have undergone THA using a direct-anterior surgical approach and will undergo fluoroscopy surveillance while walking. Fluoroscopy surveillance of patients while walking: While each subject performs a gait activity (normal walking) under fluoroscopic surveillance on a level treadmill, a data acquisition (DAQ) system will be used to determine the vibrations/sounds occurring during walking.
THA Using Anterior-lateral Approach
n=10 Participants
Patients will have undergone THA using an anterior-lateral surgical approach and will undergo fluoroscopy surveillance while walking. Fluoroscopy surveillance of patients while walking: While each subject performs a gait activity (normal walking) under fluoroscopic surveillance on a level treadmill, a data acquisition (DAQ) system will be used to determine the vibrations/sounds occurring during walking.
THA Using Posterior-lateral Approach
n=10 Participants
Patients will have undergone THA using a posterior-lateral surgical approach and will undergo fluoroscopy surveillance while walking. Fluoroscopy surveillance of patients while walking: While each subject performs a gait activity (normal walking) under fluoroscopic surveillance on a level treadmill, a data acquisition (DAQ) system will be used to determine the vibrations/sounds occurring during walking.
Total
n=30 Participants
Total of all reporting groups
Age, Continuous
63 years
STANDARD_DEVIATION 7.3 • n=99 Participants
67 years
STANDARD_DEVIATION 5.4 • n=107 Participants
69 years
STANDARD_DEVIATION 8.7 • n=206 Participants
66 years
STANDARD_DEVIATION 7.4 • n=7 Participants
Age, Categorical
<=18 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
0 Participants
n=7 Participants
Age, Categorical
Between 18 and 65 years
6 Participants
n=99 Participants
3 Participants
n=107 Participants
3 Participants
n=206 Participants
12 Participants
n=7 Participants
Age, Categorical
>=65 years
4 Participants
n=99 Participants
7 Participants
n=107 Participants
7 Participants
n=206 Participants
18 Participants
n=7 Participants
Sex: Female, Male
Female
5 Participants
n=99 Participants
4 Participants
n=107 Participants
9 Participants
n=206 Participants
18 Participants
n=7 Participants
Sex: Female, Male
Male
5 Participants
n=99 Participants
6 Participants
n=107 Participants
1 Participants
n=206 Participants
12 Participants
n=7 Participants
Region of Enrollment
United States
10 participants
n=99 Participants
0 participants
n=107 Participants
10 participants
n=206 Participants
20 participants
n=7 Participants
Region of Enrollment
Canada
0 participants
n=99 Participants
10 participants
n=107 Participants
0 participants
n=206 Participants
10 participants
n=7 Participants

PRIMARY outcome

Timeframe: 6 months post-operatively

Determine amount of in vivo swing phase hip separation present within implanted hip during weight-bearing level walking while under fluoroscopic surveillance.

Outcome measures

Outcome measures
Measure
THA Using Direct-anterior Surgical Approach
n=10 Participants
Patients will have undergone THA using a direct-anterior surgical approach and will undergo fluoroscopy surveillance while walking. Fluoroscopy surveillance of patients while walking: While each subject performs a gait activity (normal walking) under fluoroscopic surveillance on a level treadmill, a data acquisition (DAQ) system will be used to determine the vibrations/sounds occurring during walking.
THA Using Anterior-lateral Approach
n=10 Participants
Patients will have undergone THA using an anterior-lateral surgical approach and will undergo fluoroscopy surveillance while walking. Fluoroscopy surveillance of patients while walking: While each subject performs a gait activity (normal walking) under fluoroscopic surveillance on a level treadmill, a data acquisition (DAQ) system will be used to determine the vibrations/sounds occurring during walking.
THA Using Posterior-lateral Approach
n=10 Participants
Patients will have undergone THA using a posterior-lateral surgical approach and will undergo fluoroscopy surveillance while walking. Fluoroscopy surveillance of patients while walking: While each subject performs a gait activity (normal walking) under fluoroscopic surveillance on a level treadmill, a data acquisition (DAQ) system will be used to determine the vibrations/sounds occurring during walking.
Kinematics - Swing Phase Separation
0.9 mm
Standard Deviation 0.7
0.6 mm
Standard Deviation 0.3
1.0 mm
Standard Deviation 0.4

PRIMARY outcome

Timeframe: 6 months post-operative

Determine amount of stance phase hip separation present in vivo of implanted hip during level walking activity under fluoroscopic surveillance.

Outcome measures

Outcome measures
Measure
THA Using Direct-anterior Surgical Approach
n=10 Participants
Patients will have undergone THA using a direct-anterior surgical approach and will undergo fluoroscopy surveillance while walking. Fluoroscopy surveillance of patients while walking: While each subject performs a gait activity (normal walking) under fluoroscopic surveillance on a level treadmill, a data acquisition (DAQ) system will be used to determine the vibrations/sounds occurring during walking.
THA Using Anterior-lateral Approach
n=10 Participants
Patients will have undergone THA using an anterior-lateral surgical approach and will undergo fluoroscopy surveillance while walking. Fluoroscopy surveillance of patients while walking: While each subject performs a gait activity (normal walking) under fluoroscopic surveillance on a level treadmill, a data acquisition (DAQ) system will be used to determine the vibrations/sounds occurring during walking.
THA Using Posterior-lateral Approach
n=10 Participants
Patients will have undergone THA using a posterior-lateral surgical approach and will undergo fluoroscopy surveillance while walking. Fluoroscopy surveillance of patients while walking: While each subject performs a gait activity (normal walking) under fluoroscopic surveillance on a level treadmill, a data acquisition (DAQ) system will be used to determine the vibrations/sounds occurring during walking.
Kinematics - Stance Phase Separation
0.9 mm
Standard Deviation 0.3
0.8 mm
Standard Deviation 0.6
1.0 mm
Standard Deviation 0.3

PRIMARY outcome

Timeframe: 6 months post-operative

Determine overall hip separation present in vivo in implanted hip during level walking activity under fluoroscopic surveillance

Outcome measures

Outcome measures
Measure
THA Using Direct-anterior Surgical Approach
n=10 Participants
Patients will have undergone THA using a direct-anterior surgical approach and will undergo fluoroscopy surveillance while walking. Fluoroscopy surveillance of patients while walking: While each subject performs a gait activity (normal walking) under fluoroscopic surveillance on a level treadmill, a data acquisition (DAQ) system will be used to determine the vibrations/sounds occurring during walking.
THA Using Anterior-lateral Approach
n=10 Participants
Patients will have undergone THA using an anterior-lateral surgical approach and will undergo fluoroscopy surveillance while walking. Fluoroscopy surveillance of patients while walking: While each subject performs a gait activity (normal walking) under fluoroscopic surveillance on a level treadmill, a data acquisition (DAQ) system will be used to determine the vibrations/sounds occurring during walking.
THA Using Posterior-lateral Approach
n=10 Participants
Patients will have undergone THA using a posterior-lateral surgical approach and will undergo fluoroscopy surveillance while walking. Fluoroscopy surveillance of patients while walking: While each subject performs a gait activity (normal walking) under fluoroscopic surveillance on a level treadmill, a data acquisition (DAQ) system will be used to determine the vibrations/sounds occurring during walking.
Kinematics - Overall Separation
1.1 mm
Standard Deviation 0.6
0.8 mm
Standard Deviation 0.6
1.2 mm
Standard Deviation 0.4

Adverse Events

THA Using Direct-anterior Surgical Approach

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

THA Using Anterior-lateral Approach

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

THA Using Posterior-lateral Approach

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Richard D. Komistek

University of Tennessee

Phone: 8659742093

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place